Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm
Background: Marfan syndrome (MFS) is an autosomal dominant disorder of the connective tissue caused by mutations in the FBN1 (fibrillin-1) gene encoding a large glycoprotein in the extracellular matrix called fibrillin-1. The major complication of this connective disorder is the risk to develop thor...
| Autores: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de publicación: | 2021 |
| País: | España |
| Recursos: | Universidad Complutense de Madrid (UCM) |
| Repositorio: | Docta Complutense |
| Idioma: | inglés |
| OAI Identifier: | oai:docta.ucm.es:20.500.14352/94925 |
| Acesso em linha: | https://hdl.handle.net/20.500.14352/94925 |
| Access Level: | acceso abierto |
| Palavra-chave: | 576.311.317 Aortic aneurysm DNA Mitochondrial Extracellular matrix Genetic diseases Inborn Glycolysis Marfan syndrome Muscle Smooth Vascular Biología celular (Biología) Cardiología 2407 Biología Celular |
| id |
ES_f33eea4c3b2602bbf13eef131ad80e30 |
|---|---|
| oai_identifier_str |
oai:docta.ucm.es:20.500.14352/94925 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic AneurysmOller, JorgeGabandé-Rodriguez, EnriqueRuiz-Rodríguez, Maria JesúsDesdín-Micó, GabrielaAranda Gómez, Juan FranciscoBallesteros-Rodríguez, ConstanzaBlanco, Eva MariaRoldán-Montero, RaquelAcuña, PedroForteza-Gil, AlbertoMartín-López, CarlosNistal, FranciscoLino Cardenas, ChristianEvan, LindsayMartín-Vertura, Jose LuisBriones, AnaRedondo, Juan MiguelMittelbrunn, María576.311.317Aortic aneurysmDNAMitochondrialExtracellular matrixGenetic diseasesInbornGlycolysisMarfan syndromeMuscleSmoothVascularBiología celular (Biología)Cardiología2407 Biología CelularBackground: Marfan syndrome (MFS) is an autosomal dominant disorder of the connective tissue caused by mutations in the FBN1 (fibrillin-1) gene encoding a large glycoprotein in the extracellular matrix called fibrillin-1. The major complication of this connective disorder is the risk to develop thoracic aortic aneurysm. To date, no effective pharmacologic therapies have been identified for the management of thoracic aortic disease and the only options capable of preventing aneurysm rupture are endovascular repair or open surgery. Here, we have studied the role of mitochondrial dysfunction in the progression of thoracic aortic aneurysm and mitochondrial boosting strategies as a potential treatment to managing aortic aneurysms. Methods: Combining transcriptomics and metabolic analysis of aortas from an MFS mouse model (Fbn1c1039g/+) and MFS patients, we have identified mitochondrial dysfunction alongside with mtDNA depletion as a new hallmark of aortic aneurysm disease in MFS. To demonstrate the importance of mitochondrial decline in the development of aneurysms, we generated a conditional mouse model with mitochondrial dysfunction specifically in vascular smooth muscle cells (VSMC) by conditional depleting Tfam (mitochondrial transcription factor A; Myh11-CreERT2Tfamflox/flox mice). We used a mouse model of MFS to test for drugs that can revert aortic disease by enhancing Tfam levels and mitochondrial respiration. Results: The main canonical pathways highlighted in the transcriptomic analysis in aortas from Fbn1c1039g/+ mice were those related to metabolic function, such as mitochondrial dysfunction. Mitochondrial complexes, whose transcription depends on Tfam and mitochondrial DNA content, were reduced in aortas from young Fbn1c1039g/+ mice. In vitro experiments in Fbn1-silenced VSMCs presented increased lactate production and decreased oxygen consumption. Similar results were found in MFS patients. VSMCs seeded in matrices produced by Fbn1-deficient VSMCs undergo mitochondrial dysfunction. Conditional Tfam-deficient VSMC mice lose their contractile capacity, showed aortic aneurysms, and died prematurely. Restoring mitochondrial metabolism with the NAD precursor nicotinamide riboside rapidly reverses aortic aneurysm in Fbn1c1039g/+ mice. Conclusions: Mitochondrial function of VSMCs is controlled by the extracellular matrix and drives the development of aortic aneurysm in Marfan syndrome. Targeting vascular metabolism is a new available therapeutic strategy for managing aortic aneurysms associated with genetic disorders.Universidad Complutense de Madrid20212021-01-0120212021-01-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/94925reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)InglésengEC PF7 Not available 715322open accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/949252026-06-02T12:44:21Z |
| dc.title.none.fl_str_mv |
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm |
| title |
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm |
| spellingShingle |
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm Oller, Jorge 576.311.317 Aortic aneurysm DNA Mitochondrial Extracellular matrix Genetic diseases Inborn Glycolysis Marfan syndrome Muscle Smooth Vascular Biología celular (Biología) Cardiología 2407 Biología Celular |
| title_short |
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm |
| title_full |
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm |
| title_fullStr |
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm |
| title_full_unstemmed |
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm |
| title_sort |
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm |
| dc.creator.none.fl_str_mv |
Oller, Jorge Gabandé-Rodriguez, Enrique Ruiz-Rodríguez, Maria Jesús Desdín-Micó, Gabriela Aranda Gómez, Juan Francisco Ballesteros-Rodríguez, Constanza Blanco, Eva Maria Roldán-Montero, Raquel Acuña, Pedro Forteza-Gil, Alberto Martín-López, Carlos Nistal, Francisco Lino Cardenas, Christian Evan, Lindsay Martín-Vertura, Jose Luis Briones, Ana Redondo, Juan Miguel Mittelbrunn, María |
| author |
Oller, Jorge |
| author_facet |
Oller, Jorge Gabandé-Rodriguez, Enrique Ruiz-Rodríguez, Maria Jesús Desdín-Micó, Gabriela Aranda Gómez, Juan Francisco Ballesteros-Rodríguez, Constanza Blanco, Eva Maria Roldán-Montero, Raquel Acuña, Pedro Forteza-Gil, Alberto Martín-López, Carlos Nistal, Francisco Lino Cardenas, Christian Evan, Lindsay Martín-Vertura, Jose Luis Briones, Ana Redondo, Juan Miguel Mittelbrunn, María |
| author_role |
author |
| author2 |
Gabandé-Rodriguez, Enrique Ruiz-Rodríguez, Maria Jesús Desdín-Micó, Gabriela Aranda Gómez, Juan Francisco Ballesteros-Rodríguez, Constanza Blanco, Eva Maria Roldán-Montero, Raquel Acuña, Pedro Forteza-Gil, Alberto Martín-López, Carlos Nistal, Francisco Lino Cardenas, Christian Evan, Lindsay Martín-Vertura, Jose Luis Briones, Ana Redondo, Juan Miguel Mittelbrunn, María |
| author2_role |
author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Universidad Complutense de Madrid |
| dc.subject.none.fl_str_mv |
576.311.317 Aortic aneurysm DNA Mitochondrial Extracellular matrix Genetic diseases Inborn Glycolysis Marfan syndrome Muscle Smooth Vascular Biología celular (Biología) Cardiología 2407 Biología Celular |
| topic |
576.311.317 Aortic aneurysm DNA Mitochondrial Extracellular matrix Genetic diseases Inborn Glycolysis Marfan syndrome Muscle Smooth Vascular Biología celular (Biología) Cardiología 2407 Biología Celular |
| description |
Background: Marfan syndrome (MFS) is an autosomal dominant disorder of the connective tissue caused by mutations in the FBN1 (fibrillin-1) gene encoding a large glycoprotein in the extracellular matrix called fibrillin-1. The major complication of this connective disorder is the risk to develop thoracic aortic aneurysm. To date, no effective pharmacologic therapies have been identified for the management of thoracic aortic disease and the only options capable of preventing aneurysm rupture are endovascular repair or open surgery. Here, we have studied the role of mitochondrial dysfunction in the progression of thoracic aortic aneurysm and mitochondrial boosting strategies as a potential treatment to managing aortic aneurysms. Methods: Combining transcriptomics and metabolic analysis of aortas from an MFS mouse model (Fbn1c1039g/+) and MFS patients, we have identified mitochondrial dysfunction alongside with mtDNA depletion as a new hallmark of aortic aneurysm disease in MFS. To demonstrate the importance of mitochondrial decline in the development of aneurysms, we generated a conditional mouse model with mitochondrial dysfunction specifically in vascular smooth muscle cells (VSMC) by conditional depleting Tfam (mitochondrial transcription factor A; Myh11-CreERT2Tfamflox/flox mice). We used a mouse model of MFS to test for drugs that can revert aortic disease by enhancing Tfam levels and mitochondrial respiration. Results: The main canonical pathways highlighted in the transcriptomic analysis in aortas from Fbn1c1039g/+ mice were those related to metabolic function, such as mitochondrial dysfunction. Mitochondrial complexes, whose transcription depends on Tfam and mitochondrial DNA content, were reduced in aortas from young Fbn1c1039g/+ mice. In vitro experiments in Fbn1-silenced VSMCs presented increased lactate production and decreased oxygen consumption. Similar results were found in MFS patients. VSMCs seeded in matrices produced by Fbn1-deficient VSMCs undergo mitochondrial dysfunction. Conditional Tfam-deficient VSMC mice lose their contractile capacity, showed aortic aneurysms, and died prematurely. Restoring mitochondrial metabolism with the NAD precursor nicotinamide riboside rapidly reverses aortic aneurysm in Fbn1c1039g/+ mice. Conclusions: Mitochondrial function of VSMCs is controlled by the extracellular matrix and drives the development of aortic aneurysm in Marfan syndrome. Targeting vascular metabolism is a new available therapeutic strategy for managing aortic aneurysms associated with genetic disorders. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021 2021-01-01 2021 2021-01-01 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/20.500.14352/94925 |
| url |
https://hdl.handle.net/20.500.14352/94925 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.relation.none.fl_str_mv |
EC PF7 Not available 715322 |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Docta Complutense instname:Universidad Complutense de Madrid (UCM) |
| instname_str |
Universidad Complutense de Madrid (UCM) |
| reponame_str |
Docta Complutense |
| collection |
Docta Complutense |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869424359424131072 |
| score |
15,300719 |